PF-Atlas › Mechanisms › ROCK Inhibition

ROCK Inhibition in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

ROCK Inhibition is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting ROCK Inhibition

Fasudil

Clinical trials

Fasudil — FASUDIL-IPF
Medical disclaimer. This is a research summary, not medical advice.